Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Natalizumab an effective and safety therapy in patients with multiple sclerosis

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: TORRES, Maria Alexandra (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, Coimbra, Portugal)
  • Co-author(s): Campelo, Isabel (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
    Rodrigues, Ana Isabel (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
    Rocha, Marilia (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
    Cabral, Maria Adelaide (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
  • Abstract:

    Objective: The aim of the present study was to evaluate the effectiveness and safety of the new therapeutic agent, Natalizumab. Design: A three year (2007-2009) retrospective study of patients admitted to the three Neurology wards. Data were collected by physicians and the neurology pharmacist during the outpatient visit. Main Outcome Measures:..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses